124 related articles for article (PubMed ID: 38097460)
21. Predictors of malignancy in patients with solitary pulmonary nodules undergoing pulmonary resection.
Erdogdu E; Ozkan B; Duman S; Agkoc M; Erturk SM; Kara M; Toker A
Clin Respir J; 2022 May; 16(5):361-368. PubMed ID: 35474637
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Accuracy of CT-Guided Percutaneous Pulmonary Biopsy for Distinguishing Benign and Malignant Solitary Pulmonary Nodules.
Li X; Jin F; Zhou T; Ru Y; Gu F; Wang L; Chen J
Altern Ther Health Med; 2023 Nov; 29(8):918-923. PubMed ID: 37773650
[TBL] [Abstract][Full Text] [Related]
23. Is the Yedikule-solitary pulmonary nodule malignancy risk score sufficient to predict malignancy? An internal validation study.
Erdoğu V; Çitak N; Yerlioğlu A; Aksoy Y; Emetli Y; Pekçolaklar A; Saydam Ö; Metin M
Interact Cardiovasc Thorac Surg; 2021 Jul; 33(2):258-265. PubMed ID: 33792653
[TBL] [Abstract][Full Text] [Related]
24. [Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule].
Martins Rde C; Almeida SA; Siciliano AA; Landesmann MC; Silva FB; Franco CA; Fonseca LM
J Bras Pneumol; 2008 Jul; 34(7):473-80. PubMed ID: 18695792
[TBL] [Abstract][Full Text] [Related]
25. A decision tree model to distinguish between benign and malignant pulmonary nodules on CT scans.
Ma XB; Xu QL; Li N; Wang LN; Li HC; Jiang SJ
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5692-5699. PubMed ID: 37401307
[TBL] [Abstract][Full Text] [Related]
26. [Development of a predicting model to estimate the probability of malignancy of solitary pulmonary nodules].
Tian R; Su MG; Tian Y; Li FL; Kuang AR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):404-8. PubMed ID: 22812247
[TBL] [Abstract][Full Text] [Related]
27. Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary nodule.
Mery CM; Pappas AN; Bueno R; Mentzer SJ; Lukanich JM; Sugarbaker DJ; Jaklitsch MT
Chest; 2004 Jun; 125(6):2175-81. PubMed ID: 15189939
[TBL] [Abstract][Full Text] [Related]
28. Solitary pulmonary nodule malignancy predictive models applicable to routine clinical practice: a systematic review.
Senent-Valero M; Librero J; Pastor-Valero M
Syst Rev; 2021 Dec; 10(1):308. PubMed ID: 34872592
[TBL] [Abstract][Full Text] [Related]
29. Nomogram combining clinical and radiological characteristics for predicting the malignant probability of solitary pulmonary nodules measuring ≤ 2 cm.
Xue M; Li R; Wang K; Liu W; Liu J; Li Z; Ma Z; Zhang H; Tian H; Tian Y
Front Oncol; 2023; 13():1196778. PubMed ID: 37795448
[TBL] [Abstract][Full Text] [Related]
30. Development of a diagnostic model for malignant solitary pulmonary nodules based on radiomics features.
Zhao W; Zou C; Li C; Li J; Wang Z; Chen L
Ann Transl Med; 2022 Feb; 10(4):201. PubMed ID: 35280381
[TBL] [Abstract][Full Text] [Related]
31. Correlation study between dual source CT perfusion imaging and the microvascular composition of solitary pulmonary nodules.
Wang M; Li B; Sun H; Huang T; Zhang X; Jin K; Wang F; Luo X
Lung Cancer; 2019 Apr; 130():115-120. PubMed ID: 30885331
[TBL] [Abstract][Full Text] [Related]
32. Solitary pulmonary nodules: comparison of multi-slice computed tomography perfusion study with vascular endothelial growth factor and microvessel density.
Bai RJ; Cheng XG; Qu H; Shen BZ; Han MJ; Wu ZH
Chin Med J (Engl); 2009 Mar; 122(5):541-7. PubMed ID: 19323905
[TBL] [Abstract][Full Text] [Related]
33. Decreased levels of sex hormones in females with solitary pulmonary nodules were risk factors for malignancy.
Wendan W; Mengyu L; Qiufeng Z
J Cardiothorac Surg; 2024 Mar; 19(1):119. PubMed ID: 38475837
[TBL] [Abstract][Full Text] [Related]
34. [Clinical analysis of solitary pulmonary nodule measuring less than 10 mm].
Hu WD; Liao MY; Chen JK
Ai Zheng; 2006 Feb; 25(2):217-9. PubMed ID: 16480590
[TBL] [Abstract][Full Text] [Related]
35. Developing a multi-institutional nomogram for assessing lung cancer risk in patients with 5-30 mm pulmonary nodules: a retrospective analysis.
Jiang Y; Deng T; Huang Y; Ren B; He L; Pang M; Jiang L
PeerJ; 2023; 11():e16539. PubMed ID: 38107565
[TBL] [Abstract][Full Text] [Related]
36. Malignancy risk stratification for solitary pulmonary nodule: A clinical practice guideline.
Chen B; Li Q; Hao Q; Tan J; Yan L; Zhu Y; Hu C; Qian G; Zhang G; Chen L; Zhou C; Zhang J; Sun J; Jiang L; Zhang L; Wang Q; Zhang X; Jin Y; He Y; Song Y; Sun X; Li W
J Evid Based Med; 2022 Jun; 15(2):142-151. PubMed ID: 35775869
[TBL] [Abstract][Full Text] [Related]
37. Establishment of a mathematic model for predicting malignancy in solitary pulmonary nodules.
Zhang M; Zhuo N; Guo Z; Zhang X; Liang W; Zhao S; He J
J Thorac Dis; 2015 Oct; 7(10):1833-41. PubMed ID: 26623107
[TBL] [Abstract][Full Text] [Related]
38. CT characterization of different pathological types of subcentimeter pulmonary ground-glass nodular lesions.
Gao F; Sun Y; Zhang G; Zheng X; Li M; Hua Y
Br J Radiol; 2019 Feb; 92(1094):20180204. PubMed ID: 30260240
[TBL] [Abstract][Full Text] [Related]
39. Identification of preoperative prediction factors of tumor subtypes for patients with solitary ground-glass opacity pulmonary nodules.
Li M; Wang Y; Chen Y; Zhang Z
J Cardiothorac Surg; 2018 Jan; 13(1):9. PubMed ID: 29343293
[TBL] [Abstract][Full Text] [Related]
40. The evaluation and management of the solitary pulmonary nodule.
Soubani AO
Postgrad Med J; 2008 Sep; 84(995):459-66. PubMed ID: 18940947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
